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Abstract
Objectives: Optimal depression screening necessitates measurement tools that are valid across varied populations and in
the presence of comorbidities.
Methods: This study assessed the test properties of two versions of the Center for Epidemiologic Studies Depression scale
against psychiatric diagnoses established by the Mini International Neuropsychiatric Interview among a clinical sample of US
Veterans deployed during Operations Enduring Freedom, Iraqi Freedom, and New Dawn. Participants (N = 359) recruited
from two Department of Veterans Affairs hospitals completed a clinical interview, structured diagnostic interview, and selfreported measures.
Results: Based on diagnostic interview and the Diagnostic and Statistical Manual of Mental Disorders 4th Edition criteria, 29.5%
of the sample met diagnostic criteria for major depressive disorder and 26.5% met diagnostic criteria for post-traumatic
stress disorder. Both Center for Epidemiologic Studies Depression-20 and Center for Epidemiologic Studies Depression-10
scales performed well and almost identically against the Mini International Neuropsychiatric Interview-major depressive
disorder in identifying Veterans with major depressive disorder (Center for Epidemiologic Studies Depression-20 area
under the Receiver Operating Characteristic curve 91%; Center for Epidemiologic Studies Depression-10 area under the
ROC curve 90%). Overall, higher cut points for the Center for Epidemiologic Studies Depression scales performed better
in correctly identifying true positives and true negatives for major depressive disorder (Center for Epidemiologic Studies
Depression-20 cut point 18+ sensitivity 92% specificity 72%; Center for Epidemiologic Studies Depression-10 cut point 10+
sensitivity 92% specificity 69%).
Conclusions: The specificity of the Center for Epidemiologic Studies Depression scales was poor among Veterans with cooccurring post-traumatic stress disorder (13% and 16%). Veterans with post-traumatic stress disorder who have a positive
depression screen should have a more thorough assessment of mental health symptoms and comorbidities, rather than
immediate diagnosis of and treatment for depression.
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Introduction

Methodology

Major depressive disorder (MDD) is a common mental
health problem affecting nearly one out of every six adults in
the United States.1 This condition is associated with significant disability, symptom burden, and health care costs.1,2
Identifying depression in community and primary care settings allows for targeting interventions,3 but screening tools
for depression may not be equally valid across clinical populations, or in the context of medical or other psychiatric
comorbidities.
Veterans have much higher levels of depression relative
to the general US population,4 including younger cohorts
of Veterans involved in the Iraq and Afghanistan conflicts.5
Veterans are also at higher risk for other debilitating mental health conditions, including post-traumatic stress disorder (PTSD) and traumatic brain injury.6–8 Adequately
assessing health needs of returning service members is
important both for providing clinical care and allocating
resources.
The accurate identification of MDD may pose significant
challenges because it co-occurs and overlaps with other
mental health conditions. A number of widely used scales
may accurately identify depressive symptoms, although
they may not correlate entirely with a clinical diagnosis.
The Center for Epidemiologic Studies Depression scale
(CES-D) has wide applicability and utility in identifying
depressive symptoms in people with traumatic injury and
disability in VA health care settings9,10 and has consistently
demonstrated excellent screening properties for detecting
depression outcomes.11 In addition, full and shortened versions of the CES-D scale have been used to assess depression outcomes, with the shortened scale demonstrating
comparable test properties to the full scale when used as a
screening tool to identify MDD.12–14
There is a high degree of comorbidity and symptom
overlap between PTSD and MDD among Veterans.15–17
Patients with depression alone and patients with PTSD
and depression together exhibit very different disease
severities, symptomatologies, and progression. Further,
patients diagnosed with both MDD and PTSD experience
delayed response to depression treatment.16 The presence
of PTSD may thus alter the properties of depression
screening tests.
The objective of this study is to evaluate the validity of
the CES-D (the full 20-item and shortened 10-item scales)
at various cutoff points for a population of Veterans using a
gold standard established by the Mini International
Neuropsychiatric Interview (MINI-MDD). In order to
assess the validity of the full and shortened CES-D scales,
we examined the sensitivity, specificity, and receiver operating characteristic (ROC) curves. In addition, we examined these test properties for Veterans with PTSD and
without PTSD.

This was a cross-sectional study of a cohort of returned
Veterans from Operations Enduring Freedom (OEF), Iraqi
Freedom (OIF), and New Dawn (OND) who were either
receiving care or had registered for care at VA health care
facilities. Recruitment details of the study population are
described elsewhere.8

Study sites
Data were drawn from two (one northern and one southeastern) of the five VA facilities with regional inpatient
Polytrauma Rehabilitation Centers (PRCs). Both facilities
are large, tertiary care hospitals that provide a broad range of
comprehensive medical and mental health care, and both
maintain a comprehensive list (OEF/OIF/OND registry) of
current or former service members who have applied for VA
services in their region. Full details of the parent study protocols, informed consent procedures, and Institutional
Review Board approvals are published elsewhere.8 Informed
consent procedures were approved by the Institutional
Review Boards and Research and Development Committees
for each of the two VA facilities (one northern and one southeastern) that conducted participant enrollment and data collection. As secondary data analysis of existing, de-identified
clinical information, the current study was exempt from
human subject review by the Institutional Review Board of
Oregon Health & Science University.

Eligibility and recruitment
Eligible participants were deployed during OEF/OIF/OND
between October 2001 through September 2010, able to read
and write in English, and able to complete study forms,
scales, and provide informed consent. Eligible individuals
with moderate to high traumatic brain injury and who met
criteria for minimal to moderate cognitive impairment18
required clearance by an attending physician in order to
participate.

Measures
Electronic health record data. Descriptive information was
extracted from electronic health records, including demographic information, physical and psychiatric diagnoses, and
health history.
MINI diagnostic interviews. Psychiatric diagnoses were
obtained via the MINI.19 The MINI is a brief, validated,
structured clinical interview designed to provide reliable
Axis I psychiatric diagnoses in accordance with the Diagnostic and Statistical Manual of Mental Disorders (DSMIV) for various psychiatric disorders.20 The MINI battery of
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clinical interviews administered to the study population
yields diagnoses for a number of psychiatric conditions,
including MDD and PTSD. Each MINI measure was dichotomized as having met criteria for having the condition or not,
using the established cut points.19
Depressive symptoms. Depressive symptomatology was
assessed using the full, self-reported 20-item Center for Epidemiologic Studies-Depression Scale (CESD-20) as well as the
shortened 10-item CES-D (CESD-10) (see Appendix 1).12,21
Total scores range from 0 to 60 for the CESD-20 scale and
from 0 to 30 for the CESD-10, with higher scores indicating
greater depressive symptoms. Previously, while the norm for
the cut point of the CESD-20 has been 16 points, some authors
have argued for cut points at 20 or above.22–24 We assessed
various cut points: 16+ and 18+ for the CESD-20 and 8+ and
10+ for the CESD-10.12,13,25

Statistical analyses
We assessed the validity of the CESD-20 and CESD-10
against MDD, as defined by the MINI diagnostic interview.
We assessed the sensitivity and specificity of the CESD-10
and the CESD-20 against the MINI-MDD. More specific
properties of the CES-D scales were examined with ROC
curves. The area under the ROC curve is interpreted as the
probability that the result of the diagnostic test of a randomly
selected individual with MDD will be greater than the result
of the same diagnostic test from a randomly selected healthy
individual. This approach also can be used to delineate cut
points for the scales. The greater the area under the ROC
curve the better the diagnostic test performs. We used the
cut-offs of 0.9–1 to indicate excellent accuracy versus the
MINI, 0.8–0.9 to indicate good accuracy, and 0.7–0.8 to
indicate fair accuracy.26 Because PTSD is a highly significant and frequently co-occurring condition for this population, we examined whether the performance of the CES-D
was similar among Veterans with and without PTSD using
the MINI-PTSD diagnostic assessment. We used Stata version 13.1 to conduct all analyses.

Results
This study included 359 Veterans, 91% of whom were male.
The mean age was 35 years. The sample demographic characteristics are summarized in Table 1. Most participants were
married or living with a partner (59%) and the vast majority
were non-Hispanic white (77%). Few medical comorbidities
were assessed in this population. 56% were experiencing
clinically significant pain (assessed by a rating of usual pain
intensity over the last week of >3 on the Numeric Rating
Scale, ranging from 0 to 10) and 16% reported postconcussional disorder (assessed using DSM-IV diagnostic criteria).
The MINI psychiatric interviews identified sample

Table 1. Descriptive results of a sample of n = 359 US Veterans
of Operations Enduring Freedom (OEF) Iraqi Freedom (OIF)
New Dawn (OND).
Characteristic

N (%)

Men
Age
Marital status
Married
Co-habitating
Divorced/separated
Never married
Years education (n = 356)
Race
Non-Hispanic white
Non-Hispanic black
Hispanic
Asian
Other
Clinically Significant Paina
Post-concussional disorder
Met criteria:
MINI-MDD
MINI-PTSD
MINI-Dysthymia
MINI-Panic disorder
MINI-ETOH dependence
MINI-Psychotic conditions
MINI-Agoraphobia
MINI-Hypomania or mania
MINI-Social phobia
CESD-20
 Positive for depressive
symptoms (16+ points)
 Positive for depressive
symptoms (18+ points)
CESD-10
 Positive for depressive
symptoms (8+ points)
 Positive for depressive
symptoms (10+ points)

327 (91)

Mean (SD)

Range

35.1 (9.7)

20–66

14.5 (2.0)

12–22

18.5 (12.9)

0–56

10.2 (7.2)

0–30

188 (52)
24 (6.7)
60 (16.7)
87 (24.2)

278 (77.4)
34 (9.5)
38 (10.6)
6 (1.7)
3 (0.8)
201 (56)
58 (16.2)
106 (29.5)
95 (26.5)
21 (6.6)
65 (18.1)
50 (13.9)
18 (5)
103 (28.7)
83 (23.1)
34 (9.5)
182 (50.7)
169 (47.1)

205 (57.1)
175 (48.7)

SD: standard deviation; MINI-MDD: Mini International Neuropsychiatric
Interview Diagnosis for Major Depressive Disorder; MINI-PTSD: Mini
International Neuropsychiatric Interview Diagnosis for Post-Traumatic
Stress Disorder; CES-D: Center for Epidemiologic Studies Depression
Scale.
aClinically Significant Pain was defined as “usual” pain intensity over the
last week rated as >3 on the Numeric Rating Scale (range 0–10).

population prevalence of 29.5% for MDD, 26.5% for PTSD,
28.7% for agoraphobia, 23.1% for hypomania or mania,
18.1% for panic disorder, and 13.9% for alcohol dependence. Approximately half of the study population scored
above the lower cut points on the CES-D depressive symptoms scales. The mean score for depressive symptoms was
18.5 for the CESD-20; for the CESD-10 the mean was 10.2.
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Table 2. Descriptive information for condition overlap between MINI-MDD and MINI-PTSD (met criteria) among US Veterans of OEF/
OIF/OND.
Condition overlap for MINI-MDD and MINI-PTSD (met criteria), n (percent of total)

MINI-PTSD Positive
MINI-PTSD Negative

MINI-MDD Positive

MINI-MDD Negative

64 (18%)
42 (12%)

31 (9%)
222 (62%)

CESD-20 and CESD-10 scores based on MINI-MDD and MINI-PTSD categories, mean(sd)

MINI-PTSD Positive
MINI-PTSD Negative

MINI-MDD Positive

MINI-MDD Negative

34.0 (8.8)/18.6 (4.6)
28.3 (10.2)/15.8 (5.7)

25.4 (8.7)/14.1 (5.3)
11.1 (8.3)/6.2 (4.8)

MINI-MDD: Mini International Neuropsychiatric Interview Diagnosis for Major Depressive Disorder; MINI-PTSD: Mini International Neuropsychiatric
Interview Diagnosis for Post-Traumatic Stress Disorder; SD: standard deviation; CES-D: Center for Epidemiologic Studies Depression Scale.

Figure 1. Receiver Operating Characteristic (ROC) curves for MINI-major depressive disorder and CES-D.

Both the CESD-20 and CESD-10 performed well against
the MINI-MDD in identifying MDD at the various cut points
examined (Table 2; Figure 1). The test properties of the
CESD-20 were comparable for the 16+ cut point (sensitivity
95%, specificity 68%, area under ROC curve 91%) and the
18+ cut point (sensitivity 92%, specificity 72%, area under
ROC curve 91%). For the CESD-10, the test properties were
also fairly similar for the 8+ cut point (sensitivity 97%, specificity 60%, area under the ROC curve 90%) compared to the
10+ cut point (sensitivity 92%, specificity 69%, area under
ROC curve 90%). Figure 1 illustrates the excellent test properties of the full and shortened CES-D scales against the
MINI-MDD, and the very similar performance of the two
CES-D scales.
The stratified analyses by Veterans with and without
PTSD showed differences in the performance of the CES-D
against the MINI-MDD. We examined both CES-D scales at
the higher cut points because of the comparable test properties and higher specificities demonstrated by the CESD-20 at
the 18+ cut point and the CESD-10 at the 10+ cut point. Both
scales were more accurate in identifying MDD for Veterans

without PTSD (for CESD-20: sensitivity 81%, specificity
80%, area under ROC curve 90%; for CESD-10: sensitivity
81%, specificity 77%, area under ROC curve 89%) (Table 3;
bottom of Figure 2). For Veterans with PTSD, however, the
specificity was quite low for both the CESD-20 (sensitivity
98%, 13% specificity, area under ROC curve 75%) and
CESD-10 (sensitivity 98%, specificity 16%, area under ROC
curve 73%) (Top of Figure 2; Table 4).

Discussion
Using data based on face-to-face clinical interviews and a
validated clinical assessment tool as the gold standard, we
found that both the CESD-20 and CESD-10 demonstrated
excellent test properties in classifying MDD. We found only
small differences in test properties between the CESD-20
and the CESD-10 against the MINI-MDD in any of our analyses. There was no evidence that the longer CESD-20 scale
provided any meaningful benefits. We found moderate support for using the higher diagnostic cut points on both scales.
Our results confirm the utility of using the CES-D scale, and
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Table 3. Validity of Center for Epidemiologic Studies
Depression Scale (CES-D) Versions compared to the mini
international neuropsychiatric interview among US Veterans of
OEF/OIF/OND.
Major Depressive Disorder
using Mini International
Neuropsychiatric Interview
CESD-20 (cut point 16+)
Sensitivity
Specificity
Area under ROC curve
CESD-20 (cut point 18+)
Sensitivity
Specificity
Area under ROC curve
CESD-10 (cut point 8+)
Sensitivity
Specificity
Area under ROC curve
CESD-10 (cut point 10+)
Sensitivity
Specificity
Area under ROC curve

95.28%
67.98%
0.91
91.51%
71.54%
0.91
97.17%
59.68%
0.90
91.51%
69.17%
0.90

CESD: Center for Epidemiologic Studies Depression Scale; ROC:
Receiver Operating Characteristic.

the shortened CESD-10 battery of questions in particular, to
screen Veterans for MDD.
Importantly, we found that the test properties of the
CES-D are different for Veterans with and without PTSD.
The CES-D scales performed better at identifying MDD for
Veterans without co-occurring PTSD. For those with cooccurring PTSD, the specificity was quite low (13% and
16%) at the cut points we used. These findings could argue
for a higher MDD cut point on the CES-D scale for Veterans
with PTSD, but doing so would diminish the sensitivity of
the tests (as seen in the upper graphs in Figure 2). Instead, we
recommend that any Veteran with PTSD who has a positive
depression screen should have a thorough assessment of
depressive symptoms and comorbidities prior to diagnosis or
treatment.
PTSD shows heterogeneous symptoms, and other research
has found substantial symptom overlap between PTSD and
MDD. Several key symptoms, especially numbness and dysphoria, appear to explain this overlap.15 Our findings are
generally consistent with research suggesting that these two
conditions may influence each other in significant ways.16,17
Our results do not resolve whether the two are part of a single general mood disorder, as has been proposed.27 In all,
18% of our study sample had co-occurring MDD and PTSD,
which was considerably higher than the 9% found in a

Figure 2. Receiver Operating Characteristic (ROC) curves for MINI-MDD and CES-D for Veterans with (n = 95) and without (n=264) PTSD.
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Table 4. Differences in validity by diagnostic subgroups among
US Veterans of OEF/OIF/OND.
Major depression using
Mini International
Neuropsychiatric Interview
CESD-20 (cut point 18+)
Veterans with PTSD
Sensitivity
Specificity
Area under ROC curve
Veterans without PTSD
Sensitivity
Specificity
Area under ROC curve
CESD-10 (cut point 10+)
Veterans with PTSD
Sensitivity
Specificity
Area under ROC curve
Veterans without PTSD
Sensitivity
Specificity
Area under ROC curve

N = 95
98.4%
12.9%
0.75
N = 264
81.0%
79.7%
0.90
N = 95
98.4%
16.1%
0.73
N = 264
81.0%
76.6%
0.89

PTSD: Post-Traumatic Stress Disorder; CESD: Center for Epidemiologic
Studies Depression Scale; ROC: Receiver Operating Characteristic.

study encourages the use of the CESD-10 scale, with a cut
point of 10, but with the caveat that the test has low specificity among Veterans with co-occurring PTSD. It is possible that screening for specific symptoms of PTSD and
depression (such as numbness and dysphoria)15 could promote more targeted mental health interventions, since the
group in this overlap seems to experience the most severe
symptoms.
Some aspects of our study may limit its clinical relevance. While the CES-D indices may be useful in identifying Veterans with likely MDD, they do not assess either
the severity of depressive symptoms, or comorbid mental
health diagnoses such as anxiety disorders, PTSD, and
substance abuse, which are important factors for clinical
care. It will be important in future research to clarify the
degree and consequences of overlap between comorbid
mental conditions27 as well as with co-occurring medical
conditions. Initial screening with the CESD-10 would
require follow-up with additional clinical history, or
another assessment tool, especially in the setting of PTSD.
However, if the goal is to maximize identification, assessment, and treatment of Veterans with MDD, the CESD-10
may be a particularly useful and viable screening tool for
Veteran populations at large.

Conclusion
population15

primary care VA
but a large number had only
one of the conditions. Additional research can identify areas
of overlap and differentiation, as well as the consequences
(such as differences in longitudinal course) of various manifestations of PTSD and MDD.
It is likely that the PHQ-9, which the VA has adopted
for use during clinical encounters,28 operates similarly to
the CES-D in terms of test properties.29 However, there has
been limited research about the test properties of the
PHQ-9 among broader Veteran populations, or about its
properties among Veterans with co-occurring PTSD.
Further examination of how the CES-D and PHQ-9 operate similarly or differently is warranted, given utility and
applicability of each in population-based and clinical settings, respectively.29
There are several advantages to using screening survey
measures. First, self-reported survey tools can quickly
ascertain information from respondents at-large. As a
result, health care systems such as the VA could feasibly
distribute the CES-D questionnaire widely to difficult-toreach populations. Second, clinical interviews such as the
MINI-MDD require face-to-face assessments of patients
conducted by trained professionals. In contrast, the CES-D
need not be administered face-to-face, and data collection
can be attained through various modes—phone-assisted
interviews, mailed paper questionnaires, or via Internet
access.30 Measures used in self-reported surveys can be
standardized for comparisons to other populations. Our

This study confirmed the predictive accuracy of the CESD20 and CESD-10 in identifying Veterans with MDD. The
CESD-20 offered no advantages. However, the specificity of
the CES-D for identifying MDD was low among Veterans
with co-occurring PTSD, which encourages more detailed
mental health assessment in that group.
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Appendix 1
The original CES-D contains 20 items. The list below shows
the original CESD-20 item notations, the corresponding
numbers for the CESD-10 in parentheses. Positive items are
in italics. Scoring is a simple sum (after reversing scores for
the positive items).
During the past week:
A1(1) I was bothered by things that usually don’t bother
me.
0 Rarely or None of the Time (Less than 1 Day)
1 Some or a Little of the Time (1–2 Days)
2 Occasionally or a Moderate Amount of Time
(3–4 Days)
3 Most or All of the Time (5–7 Days)
E5(2) I had trouble keeping my mind on what I was doing.
0
1
2
3

Rarely or None of the Time (Less than 1 Day)
Some or a Little of the Time (1–2 Days)
Occasionally or a Moderate Amount of Time
(3–4 Days)
Most or All of the Time (5–7 Days)

F6(3) I felt depressed.
0
1
2
3

Rarely or None of the Time (Less than 1 Day)
Some or a Little of the Time (1–2 Days)
Occasionally or a Moderate Amount of Time
(3–4 Days)
Most or All of the Time (5–7 Days)

G7(4) I felt that everything I did was an effort.
0
1
2
3

Rarely or None of the Time (Less than 1 Day)
Some or a Little of the Time (1-2 Days)
Occasionally or a Moderate Amount of Time
(3-4 Days)
Most or All of the Time (5-7 Days)

H8(5) I felt hopeful about the future.
0

Rarely or None of the Time (Less than 1 Day)

1
2
3

Some or a Little of the Time (1-2 Days)
Occasionally or a Moderate Amount of Time
(3-4 Days)
Most or All of the Time (5-7 Days)

J10(6) I felt fearful.
0
1
2
3

Rarely or None of the Time (Less than 1 Day)
Some or a Little of the Time (1-2 Days)
Occasionally or a Moderate Amount of Time
(3-4 Days)
Most or All of the Time (5-7 Days)

K11(7) My sleep was restless.
0
1
2
3

Rarely or None of the Time (Less than 1 Day)
Some or a Little of the Time (1-2 Days)
Occasionally or a Moderate Amount of Time
(3-4 Days)
Most or All of the Time (5-7 Days)

L12(8) I was happy.
0
1
2
3

Rarely or None of the Time (Less than 1 Day)
Some or a Little of the Time (1-2 Days)
Occasionally or a Moderate Amount of Time
(3-4 Days)
Most or All of the Time (5-7 Days)

N14(9) I felt lonely.
0
1
2
3

Rarely or None of the Time (Less than 1 Day)
Some or a Little of the Time (1-2 Days)
Occasionally or a Moderate Amount of Time
(3-4 Days)
Most or All of the Time (5-7 Days)

T20(10) I could not get “going.”
0
1
2
3

Rarely or None of the Time (Less than 1 Day)
Some or a Little of the Time (1–2 Days)
Occasionally or a Moderate Amount of Time
(3–4 Days)
Most or All of the Time (5–7 Days)

